Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $321.7800 (0.42%) ($320.2300 - $327.3800) on Thu. Mar. 1, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.03% (three month average) | RSI | 51 | Latest Price | $321.7800(0.42%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.4% a day on average for past five trading days. | Weekly Trend | REGN declines -1.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(61%) XLV(50%) IVW(43%) IWF(43%) QQQ(43%) | Factors Impacting REGN price | REGN will decline at least -1.015% in a week (0% probabilities). UUP(-10%) VIXM(-6%) TLT(-6%) TIP(-1%) SHY(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.015% (StdDev 2.03%) | Hourly BBV | 0 () | Intraday Trend | 0.4% | | | |
|
Resistance Level | $329.02 | 5 Day Moving Average | $322.39(-0.19%) | 10 Day Moving Average | $323.18(-0.43%) | 20 Day Moving Average | $329.02(-2.2%) | To recent high | -18.3% | To recent low | 1.9% | Market Cap | $34.118b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |